Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 29: 1028-1030, 1983;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christenson, R. H.
Right arrow Articles by Silverman, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christenson, R. H.
Right arrow Articles by Silverman, L. M.

Clinical Chemistry, Vol 29, 1028-1030, Copyright © 1983 by American Association for Clinical Chemistry

Interpretation of cerebrospinal fluid protein assays in various neurologic diseases

RH Christenson, P Behlmer, JF Howard Jr, JB Winfield and LM Silverman

Albumin and immunoglobulin G (IgG) were determined in cerebrospinal fluid (CSF) and serum, and the CSF/serum albumin Index (CSF X 10(3)/serum albumin concentration ratio) and IgG Index [(CSF/serum IgG)/(CSF/serum albumin)] were calculated. Data for these indices and oligoclonal banding are described in 23 cases of multiple sclerosis (MS), 19 of systemic lupus erythematosus (SLE), eight of sarcoidosis, 48 cases of miscellaneous disease, and 25 control patients with nonspecific complaints. Of the MS, SLE, and sarcoidosis patient groups, 8.5%, 26%, and 12.5% showed an abnormally high CSF/serum albumin Index; 87%, 16%, and 0% an increased IgG Index; and 87.5%, 42% and 0% showed positive oligoclonal banding. IgG Index and oligoclonal banding results for MS patients differed significantly from the sarcoidosis (p less than .001) and SLE (p less than .05) groups. When the CSF/serum albumin Index is considered also, the control and sarcoidosis patient results differ significantly from the MS group (p less than .001 and p less than .01). A strong correlation between the IgG Index and oligoclonal banding is implicated.


The following articles in journals at HighWire Press have cited this article:


Home page
 Ann Rheum DisHome page
K Warnatz, H H Peter, M Schumacher, L Wiese, A Prasse, F Petschner, P Vaith, B Volk, and S M Weiner
Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature
Ann Rheum Dis, January 1, 2003; 62(1): 50 - 57.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
W. Krivit, E. G. Shapiro, C. Peters, J. E. Wagner, G. Cornu, J. Kurtzberg, D. A. Wenger, E. H. Kolodny, M. T. Vanier, D. J. Loes, et al.
Hematopoietic Stem-Cell Transplantation in Globoid-Cell Leukodystrophy
N. Engl. J. Med., April 16, 1998; 338(16): 1119 - 1127.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Association for Clinical Chemistry.